EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Central α 2 ‐adrenergic mechanisms regulate human sympathetic neuronal discharge strategies

Stephen A Klassen, Jacqueline K Limberg, Ronée E Harvey, Chad C Wiggins, Nathaniel J Iannarelli, Jonathon W Senefeld, Wayne T Nicholson, Timothy B Curry, Michael J Joyner, J Kevin Shoemaker, Sarah E Baker

The Journal of Physiology · 2024

DOI: 10.1113/jp286450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Stephen A Klassen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sympathetic Neurocirculatory Regulation Laboratory, Department of Kinesiology, Brock University, St Catharines, ON, Canada. Hauptthemen laut MEDLINE: Dexmedetomidine, Adrenergic alpha-2 Receptor Agonists, Sympathetic Nervous System, Action Potentials. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study investigated the impact of central α 2 ‐adrenergic mechanisms on sympathetic action potential (AP) discharge, recruitment and latency strategies. We used the microneurographic technique to record muscle sympathetic nerve activity and a continuous wavelet transform to investigate postganglionic sympathetic AP firing during a baseline condition and an infusion of a α 2 ‐adrenergic receptor agonist, dexmedetomidine (10 min loading infusion of 0.225 µg kg −1 ; maintenance infusion of 0.1–0.5 µg kg h −1 ) in eight healthy individuals (28 ± 7 years, five females). Dexmedetomidine reduced mean pressure (92 ± 7 to 80 ± 8 mmHg, P < 0.001) but did not alter heart rate (61 ± 13 to 60 ± 14 bpm; P = 0.748). Dexmedetomidine reduced sympathetic AP discharge (126 ± 73 to 27 ± 24 AP 100 beats −1 , P = 0.003) most strongly for medium‐sized APs (normalized cluster 2: 21 ± 10 to 5 ± 5 AP 100 beats −1 ; P < 0.001). Dexmedetomidine progressively de‐recruited sympathetic APs beginning with the largest AP clusters (12 ± 3 to 7 ± 2 clusters, P = 0.002). Despite de‐recruiting large AP clusters with shorter latencies, dexmedetomidine reduced AP latency across remaining clusters (1.18 ± 0.12 to 1.13 ± 0.13 s, P = 0.002). A subset of six participants performed a Valsalva manoeuvre (20 s, 40 mmHg) during baseline and the dexmedetomidine infusion. Compared to baseline, AP discharge (Δ 361 ± 292 to Δ 113 ± 155 AP 100 beats −1 , P = 0.011) and AP cluster recruitment elicited by the Valsalva manoeuvre were lower during dexmedetomidine (Δ 2 ± 1 to Δ 0 ± 2 AP clusters, P = 0.041). The reduction in sympathetic AP latency elicited by the Valsalva manoeuvre was not affected by dexmedetomidine (Δ –0.09 ± 0.07 to Δ –0.07 ± 0.14 s, P = 0.606). Dexmedetomidine reduced baroreflex gain, most strongly for medium‐sized APs (normalized cluster 2: –6.0 ± 5 to –1.6 ± 2 % mmHg −1 ; P = 0.008). These data suggest that α 2 ‐adrenergic mechanisms within the central nervous system modulate sympathetic postganglionic neuronal discharge, recruitment and latency strategies in humans. image Key points Sympathetic postganglionic neuronal subpopulations innervating the human circulation exhibit complex patterns of discharge, recruitment and latency. However, the central neural mechanisms governing sympathetic postganglionic discharge remain unclear. This microneurographic study investigated the impact of a dexmedetomidine infusion (α 2 ‐adrenergic receptor agonist) on muscle sympathetic postganglionic action potential (AP) discharge, recruitment and latency patterns. Dexmedetomidine infusion inhibited the recruitment of large and fast conducting sympathetic APs and attenuated the discharge of medium sized sympathetic APs that fired during resting conditions and the Valsalva manoeuvre. Dexmedetomidine infusion elicited shorter sympathetic AP latencies during resting conditions but did not affect the reductions in latency that occurred during the Valsalva manoeuvre. These data suggest that α 2 ‐adrenergic mechanisms within the central nervous system modulate sympathetic postganglionic neuronal discharge, recruitment and latency strategies in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineAdrenergic alpha-2 Receptor AgonistsSympathetic Nervous SystemAction PotentialsHumansFemaleAdultMaleYoung AdultHeart RateBlood PressureMuscle, SkeletalReceptors, Adrenergic, alpha-2

Stichwörter der Autor:innen

action potentialdexmedetomidinehumanmicroneurographymuscle sympathetic nerve activityvalsalva manoeuvreα2‐adrenergic receptors

Substanzen

DexmedetomidineAdrenergic alpha-2 Receptor AgonistsReceptors, Adrenergic, alpha-2

Autor:innen und Institutionen

  • Sympathetic Neurocirculatory Regulation Laboratory, Department of Kinesiology, Brock University, St Catharines, ON, Canada.
  • Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, USA.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Kinesiology, Michigan State University, East Lansing, MI, USA.
  • Department of Health and Kinesiology, Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
  • School of Kinesiology, Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Klassen, S. A., Limberg, J. K., Harvey, R. E., Wiggins, C. C., Iannarelli, N. J., Senefeld, J. W., Nicholson, W. T., Curry, T. B., Joyner, M. J., Shoemaker, J. K., & Baker, S. E. (2024). Central α 2 ‐adrenergic mechanisms regulate human sympathetic neuronal discharge strategies. The Journal of Physiology. https://doi.org/10.1113/jp286450

Vancouver

Klassen SA, Limberg JK, Harvey RE, Wiggins CC, Iannarelli NJ, Senefeld JW, et al. Central α 2 ‐adrenergic mechanisms regulate human sympathetic neuronal discharge strategies. The Journal of Physiology. 2024. doi:10.1113/jp286450

BibTeX
@article{Klassen2024,
  author = {Klassen, Stephen A and Limberg, Jacqueline K and Harvey, Ronée E and Wiggins, Chad C and Iannarelli, Nathaniel J and Senefeld, Jonathon W and Nicholson, Wayne T and Curry, Timothy B and Joyner, Michael J and Shoemaker, J Kevin and Baker, Sarah E},
  title = {Central α 2 ‐adrenergic mechanisms regulate human sympathetic neuronal discharge strategies},
  journal = {The Journal of Physiology},
  year = {2024},
  doi = {10.1113/jp286450}
}
Kostenlos starten →